FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981623340> ?p ?o ?g. }

• W2981623340 endingPage "90" @default.
• W2981623340 startingPage "87" @default.
• W2981623340 abstract "Recently, significant advances in the prevention, diagnosis and management of breast cancer have been made. Nevertheless, worldwide, every year, 460,000 women die of breast cancer (1). The conventional approach to cancer therapy is to provide treatment according to the organ or tissue in which the cancer originates. Currently, the selection of which breast cancer therapy is based on a broad scale of factors, including a patient's age and tumour characteristics, such as nodal stage, the presence of oestrogen receptors and the Her-2/neu status (2). However, the various protocols that exist for chemo- and hormone therapy have different and limited rates of success. Often, this approach to cancer treatment is referred to as 'trial and error' or 'one-size-fits-all' (3). This practice is inefficient and frequently results in inappropriate therapy and treatment-related toxicity. In contrast, personalised treatment has the potential to increase efficacy and decrease toxicity. Nowadays, it is known that cancer develops as a result of multiple genetic defects and that individuals with the same type of cancer often have dissimilar genetic defects in their tumours (4). This finding explains why patients who seem to have similar cancers respond in a heterogeneous manner to antitumour agents and show clearly the huge obstacle to providing effective treatments for cancer. The hypothesis that stem cells play an important role in tumour biology receives a lot of attention (5). These so-called cancer stem cells (CSC) have the ability for self-renewal and are pivotal in setting the heterogeneous character of a tumour. Besides influencing the origin and growth of tumours, these CSC play an important role in developing metastasis. For personalised medicine, individual treatment regimes have to be set to define the best treatment possible for every patient. Currently, personalised treatment is most advanced for breast cancer. To achieve personalised treatment for cancer, (bio)markers for determining prognosis, predicting response to therapy, and predicting severe toxicity related to treatment are needed (3). DNA/RNA-microarrays for breast cancer prognosis, but also prediction, are very promising and at present clinical validation is ongoing (6). Recently, the use of microtechnologies for cell biology applications, and specifically for cancer, has received rapidly growing attention (7). Lab-on-a-Chip technology is a promising platform for personalised oncology to predict response or resistance to therapy, so that the individual patient receives the right drug. Even though results from in vitro assays can't be directly and uniformly translated to the in vivo situation, the in vitro approach to determining drug sensitivity and resistance continues to have great potential to spare patients the morbidity of ineffective treatment. Here, the development of a microfluidic chip ('Apoptosis chip') to screen the effect of well-known antitumour drugs on human breast cancer cells is described. Moreover, preliminary results on cancer stem cells are shown." @default.
• W2981623340 created "2019-11-01" @default.
• W2981623340 creator A5008896423 @default.
• W2981623340 creator A5012436913 @default.
• W2981623340 creator A5022234156 @default.
• W2981623340 creator A5030487900 @default.
• W2981623340 creator A5049037591 @default.
• W2981623340 creator A5064998999 @default.
• W2981623340 date "2012-01-01" @default.
• W2981623340 modified "2023-09-26" @default.
• W2981623340 title "Breast cancer research on chip" @default.
• W2981623340 cites W1508706292 @default.
• W2981623340 cites W1981989535 @default.
• W2981623340 cites W1998096683 @default.
• W2981623340 cites W1999425979 @default.
• W2981623340 cites W2026379260 @default.
• W2981623340 cites W2064086133 @default.
• W2981623340 cites W2085134335 @default.
• W2981623340 cites W2102085111 @default.
• W2981623340 cites W2103469703 @default.
• W2981623340 cites W2108868865 @default.
• W2981623340 cites W2110089988 @default.
• W2981623340 cites W2214091800 @default.
• W2981623340 hasPublicationYear "2012" @default.
• W2981623340 type Work @default.
• W2981623340 sameAs 2981623340 @default.
• W2981623340 citedByCount "0" @default.
• W2981623340 crossrefType "journal-article" @default.
• W2981623340 hasAuthorship W2981623340A5008896423 @default.
• W2981623340 hasAuthorship W2981623340A5012436913 @default.
• W2981623340 hasAuthorship W2981623340A5022234156 @default.
• W2981623340 hasAuthorship W2981623340A5030487900 @default.
• W2981623340 hasAuthorship W2981623340A5049037591 @default.
• W2981623340 hasAuthorship W2981623340A5064998999 @default.
• W2981623340 hasConcept C121608353 @default.
• W2981623340 hasConcept C126322002 @default.
• W2981623340 hasConcept C143998085 @default.
• W2981623340 hasConcept C530470458 @default.
• W2981623340 hasConcept C55427017 @default.
• W2981623340 hasConcept C60644358 @default.
• W2981623340 hasConcept C71924100 @default.
• W2981623340 hasConcept C86803240 @default.
• W2981623340 hasConceptScore W2981623340C121608353 @default.
• W2981623340 hasConceptScore W2981623340C126322002 @default.
• W2981623340 hasConceptScore W2981623340C143998085 @default.
• W2981623340 hasConceptScore W2981623340C530470458 @default.
• W2981623340 hasConceptScore W2981623340C55427017 @default.
• W2981623340 hasConceptScore W2981623340C60644358 @default.
• W2981623340 hasConceptScore W2981623340C71924100 @default.
• W2981623340 hasConceptScore W2981623340C86803240 @default.
• W2981623340 hasIssue "1" @default.
• W2981623340 hasLocation W29816233401 @default.
• W2981623340 hasOpenAccess W2981623340 @default.
• W2981623340 hasPrimaryLocation W29816233401 @default.
• W2981623340 hasRelatedWork W1020076656 @default.
• W2981623340 hasRelatedWork W152153210 @default.
• W2981623340 hasRelatedWork W1534851621 @default.
• W2981623340 hasRelatedWork W2001957097 @default.
• W2981623340 hasRelatedWork W2223327469 @default.
• W2981623340 hasRelatedWork W2226333405 @default.
• W2981623340 hasRelatedWork W2567603166 @default.
• W2981623340 hasRelatedWork W2620796872 @default.
• W2981623340 hasRelatedWork W2754824873 @default.
• W2981623340 hasRelatedWork W2772080050 @default.
• W2981623340 hasRelatedWork W2807281974 @default.
• W2981623340 hasRelatedWork W2968019715 @default.
• W2981623340 hasRelatedWork W3039352985 @default.
• W2981623340 hasRelatedWork W3111850949 @default.
• W2981623340 hasRelatedWork W3121103735 @default.
• W2981623340 hasRelatedWork W3135240988 @default.
• W2981623340 hasRelatedWork W3155932657 @default.
• W2981623340 hasRelatedWork W3193657063 @default.
• W2981623340 hasRelatedWork W70461487 @default.
• W2981623340 hasRelatedWork W2181782895 @default.
• W2981623340 hasVolume "37" @default.
• W2981623340 isParatext "false" @default.
• W2981623340 isRetracted "false" @default.
• W2981623340 magId "2981623340" @default.
• W2981623340 workType "article" @default.